These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 16896641)

  • 1. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment.
    Sano T; Kurotobi S; Matsuzaki K; Yamamoto T; Maki I; Miki K; Kogaki S; Hara J
    Eur J Pediatr; 2007 Feb; 166(2):131-7. PubMed ID: 16896641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset.
    Fukunishi M; Kikkawa M; Hamana K; Onodera T; Matsuzaki K; Matsumoto Y; Hara J
    J Pediatr; 2000 Aug; 137(2):172-6. PubMed ID: 10931407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of three intravenous gamma globulin regimens on Kawasaki disease and relevant coronary complication rates in pediatric patients: a comparative study].
    DU ZD; Zhao D; DU JB; Lu S; Yi JM; Hou AC; Zhou ZS; Ding GF;
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3119-21. PubMed ID: 18269869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease.
    Okada K; Hara J; Maki I; Miki K; Matsuzaki K; Matsuoka T; Yamamoto T; Nishigaki T; Kurotobi S; Sano T;
    Eur J Pediatr; 2009 Feb; 168(2):181-5. PubMed ID: 18446365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immune globulin plus corticosteroids in refractory Kawasaki disease.
    Jibiki T; Kato I; Shiohama T; Abe K; Anzai S; Takeda N; Yamaguchi KI; Kanazawa M; Kurosaki T
    Pediatr Int; 2011 Oct; 53(5):729-735. PubMed ID: 21342358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of laboratory predictors for intravenous immunoglobulin resistance and coronary artery aneurysm in Kawasaki Disease before and after therapy.
    Liu J; Ye B; Su D; Qin S; Zhao W; Pang Y
    Clin Rheumatol; 2023 Jan; 42(1):167-177. PubMed ID: 36129563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
    Huang XB; Zhao S; Liu ZY; Xu YY; Deng F
    Ann Med; 2023; 55(2):2264315. PubMed ID: 37870383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC; Liang CD; Wang CL; Yu HR; Hwang KP; Yang KD
    Acta Paediatr; 2010 Oct; 99(10):1578-83. PubMed ID: 20491705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
    Nandi A; Pal P; Basu S
    Rheumatol Int; 2019 Oct; 39(10):1797-1801. PubMed ID: 31302740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
    PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of efficacy among early, conventional and late intravenous gamma globulin treatment of Kawasaki disease].
    Du ZD; Di Z; Du JB; Lu S; Yi JM; Hou AC; Zhou ZS; Ding GF
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(26):1841-3. PubMed ID: 19953930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease.
    Sittiwangkul R; Pongprot Y; Silvilairat S; Phornphutkul C
    Singapore Med J; 2006 Sep; 47(9):780-4. PubMed ID: 16924360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases.
    Li X; Chen Y; Tang Y; Ding Y; Xu Q; Sun L; Qian W; Qian G; Qin L; Lv H
    Eur J Pediatr; 2018 Aug; 177(8):1279-1292. PubMed ID: 29948255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
    Sato S; Kawashima H; Kashiwagi Y; Hoshika A
    Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.
    Egami K; Muta H; Ishii M; Suda K; Sugahara Y; Iemura M; Matsuishi T
    J Pediatr; 2006 Aug; 149(2):237-40. PubMed ID: 16887442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kawasaki disease in Sicily: clinical description and markers of disease severity.
    Maggio MC; Corsello G; Prinzi E; Cimaz R
    Ital J Pediatr; 2016 Nov; 42(1):92. PubMed ID: 27806720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between ocular manifestations, laboratory findings, echocardiographic findings, and intravenous immunoglobulin resistance in Kawasaki disease.
    Jari M; Esmaeili H
    Pediatr Rheumatol Online J; 2024 May; 22(1):50. PubMed ID: 38693550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of unresponsiveness to standard high-dose gamma globulin therapy in Kawasaki disease].
    Tavli V; Yilmazer MM; Güven B; Meşe T; Oner T; Demirpençe S
    Turk Kardiyol Dern Ars; 2010 Jan; 38(1):20-4. PubMed ID: 20215838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
    Pediatr Rheumatol Online J; 2017 Mar; 15(1):17. PubMed ID: 28320400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multicenter Study of Intravenous Immunoglobulin Non-response in Kawasaki Disease.
    Wei M; Huang M; Chen S; Huang G; Huang M; Qiu D; Guo Z; Jiang J; Zhou X; Yu Q; Guo Y; Fu L; Gao W; Li F
    Pediatr Cardiol; 2015 Aug; 36(6):1166-72. PubMed ID: 25812827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.